FLULAVAL
STN: 125163
Proper Name: Influenza Vaccine
Tradename: FLULAVAL
Manufacturer: ID Biomedical Corporation of Quebec dba GlaxoSmithKline Biologicals
Indication: Active immunization against influenza in individuals 6 months and older.
Product Information
Supporting Documents
- March 23, 2026 Approval Letter - FLULAVAL
- July 1, 2025 Approval Letter - FLULAVAL
- July 1, 2024 Approval Letter - FLULAVAL
- February 6, 2020 Approval Letter - FLULAVAL
- Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent
- Statistical Review Assay - FluLaval and FluLaval Quadrivalent
- Clinical Review - FluLaval and FluLaval Quadrivalent
- Supporting Documents older than three years - FluLaval